4′-Methyl-α-pyrrolidinohexiophenone or MPHP is a stimulant compound which has been reported as a novel designer drug. It is closely related to pyrovalerone, being simply its chain-lengthened homologue

Molar mass: 259.385 g/mol

ChemSpider ID: 4928584

PubChem CID: 6423085

Formula: C17H25NO



How the MPHP Operates

Program Objective:
Our goal is to assist medical professionals by providing confidential and compassionate assistance and advocacy. Our professional staff will help you to understand the treatment options and recovery process.

Who should be referred?
The Medical Professionals Health Program helps professionals who suffer from alcohol or chemical dependency. The Program and Advisory Committee are advocates for colleagues whose health problems may compromise their professional and personal lives.

Things you should know:

  1. Confidentiality. Information shared with the program concerning a medical professional seeking or receiving assistance is confidential. Confidentiality is limited only by overreaching responsibility for public safety – issues that would forseeably result in patient harm must be reported under protocols negotiated with the licensing boards.
  2. This is a proactive program. Participating professionals are treated with compassion and understanding and encouraged to take the steps necessary to maintain personal health and professional integrity.
  3. We provide advocacy for medical professionals participating in the MPHP.
  4. All programs are operated in an ethical manner. Participants may be asked to cease practice voluntarily until they are well enough to return to practice.
  5. This program is in compliance with all applicable state laws.


There are no reviews yet.

Be the first to review “MPHP”